{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:36:55Z","timestamp":1787027815896,"version":"build-2736575974"},"reference-count":41,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Introduction: Angiosarcomas arise from vascular or lymphatic endothelial cells and can develop at any site. Visceral angiosarcomas are aggressive high-grade tumors with a high risk of recurrence, metastasis, and poor survival. Nationwide studies with long-term follow-up are limited, but crucial for understanding this malignancy. This study aimed to describe a national cohort of patients with visceral angiosarcomas and estimate long-term survival, local recurrence, and metastases. Methods: We included all adult patients in Denmark diagnosed with histologically confirmed visceral angiosarcoma from 2000 to 2017. Data were obtained from the Danish Pathology Register and the Danish Sarcoma Database, both providing nationwide and comprehensive records. Additional information on demographics, comorbidities, symptoms, diagnosis, tumor location, treatment, recurrence, and survival were collected from registries and health records. Results: Eighteen patients with visceral angiosarcoma were identified, corresponding to an incidence of one per 5.5 million inhabitants per year. The median age was 56.5 years (IQR: 50\u201370), and 56% were female. Tumors were most commonly located in the kidney, liver, and thoracic wall. Metastases were present at diagnosis in 17% and developed later in 50%. Surgery was performed in 61%, with R0 resection in 55%. Median overall survival was 249 days (IQR: 121\u2013858), and the 5-year survival rate was 11%. Only one patient (6%) remained alive at long-term follow-up. Conclusions: This Danish nationwide study confirms that visceral angiosarcomas are rare, highly aggressive tumors with a poor prognosis, consistent with international findings. Despite the small cohort, the disease demonstrated significant heterogeneity in anatomical location, metastatic pattern, and treatment approaches.<\/jats:p>","DOI":"10.3390\/cancers17132101","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T04:37:21Z","timestamp":1750739841000},"page":"2101","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Visceral Angiosarcoma: A Nationwide Population-Based Study from 2000\u20132017"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6931-4399","authenticated-orcid":false,"given":"Lasse","family":"Rehn\u00e9 Jensen","sequence":"first","affiliation":[{"name":"Department of Surgery and Transplantation, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5868-9125","authenticated-orcid":false,"given":"Christina Enciso","family":"Holm","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Rigshospitalet, University of Copenhagen, 2100 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Tolstrup","sequence":"additional","affiliation":[{"name":"Department of Surgery and Transplantation, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"\u00d8rholt","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery and Burns Treatment, Rigshospitalet, University of Copenhagen, 2100 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2324-6420","authenticated-orcid":false,"given":"Michael M\u00f8rk","family":"Petersen","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Rigshospitalet, University of Copenhagen, 2100 Copenhagen, Denmark"},{"name":"Institute of Clinical Medicine, University of Copenhagen, 2100 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8531-1865","authenticated-orcid":false,"given":"Luit","family":"Penninga","sequence":"additional","affiliation":[{"name":"Department of Surgery and Transplantation, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark"},{"name":"Institute of Clinical Medicine, University of Copenhagen, 2100 Copenhagen, Denmark"},{"name":"Department of Gastrointestinal Surgery, Aalborg University Hospital, 9000 Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S1470-2045(10)70023-1","article-title":"Angiosarcoma","volume":"11","author":"Young","year":"2010","journal-title":"Lancet Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e246235","DOI":"10.1001\/jamanetworkopen.2024.6235","article-title":"Incidence and Presenting Characteristics of Angiosarcoma in the US, 2001\u20132020","volume":"7","author":"Wagner","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11864-018-0531-3","article-title":"Current and Future Directions for Angiosarcoma Therapy","volume":"19","author":"Florou","year":"2018","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/jso.26826","article-title":"Visceral Angiosarcoma: A Nationwide Analysis of Treatment Factors and Outcomes","volume":"125","author":"Hendrick","year":"2022","journal-title":"J. Surg. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2559.2005.02288.x","article-title":"Grading of Soft Tissue Sarcomas: The Challenge of Providing Precise Information in an Imprecise World","volume":"48","author":"Deyrup","year":"2006","journal-title":"Histopathology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"109680","DOI":"10.1016\/j.ejso.2025.109680","article-title":"Clinicopathological Characteristics, Long-Term Prognosis and Follow-up Recommendations of Primary and Secondary Cutaneous Angiosarcoma: A Danish Nationwide Population-Based Cohort Study","volume":"51","author":"Abebe","year":"2025","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Holm, C.E., \u00d8rholt, M., Talman, M.-L., Abebe, K., Thorn, A., Baad-Hansen, T., and Petersen, M.M. (2024). A Population-Based Long-Term Follow-Up of Soft Tissue Angiosarcomas: Characteristics, Treatment Outcomes, and Prognostic Factors. Cancers, 16.","DOI":"10.3390\/cancers16101834"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.critrevonc.2010.10.007","article-title":"Angiosarcoma: State of the Art and Perspectives","volume":"80","author":"Penel","year":"2011","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_9","first-page":"2303","article-title":"Angiosarcoma: A Review of Diagnosis and Current Treatment","volume":"9","author":"Cao","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1245\/s10434-006-9335-y","article-title":"Treatment and Outcome of 82 Patients with Angiosarcoma","volume":"14","author":"Abraham","year":"2007","journal-title":"Ann. Surg. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.clon.2019.01.006","article-title":"Clinical Outcomes and Prognostic Features of Angiosarcoma: Significance of Prior Radiation Therapy","volume":"31","author":"Merfeld","year":"2019","journal-title":"Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hed.21513","article-title":"Outcomes after Definitive Treatment for Cutaneous Angiosarcoma of the Face and Scalp","volume":"33","author":"Guadagnolo","year":"2011","journal-title":"Head Neck"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1245\/s10434-018-7062-9","article-title":"Hepatic Angiosarcoma: A Multi-Institutional, International Experience with 44 Cases","volume":"26","author":"Wilson","year":"2019","journal-title":"Ann. Surg. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies","volume":"61","author":"Altman","year":"2008","journal-title":"J. Clin. Epidemiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2147\/CLEP.S99495","article-title":"The Danish Sarcoma Database","volume":"8","author":"Jorgensen","year":"2016","journal-title":"Clin. Epidemiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/1403494810393563","article-title":"The Danish Pathology Register","volume":"39","author":"Bjerregaard","year":"2011","journal-title":"Scand. J. Public Health"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish Civil Registration System as a Tool in Epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur. J. Epidemiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1136\/jclinpath-2017-204601","article-title":"Cutaneous Angiosarcoma: A Current Update","volume":"70","author":"Shustef","year":"2017","journal-title":"J. Clin. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/jjco\/hyaa017","article-title":"A Pooled Analysis of Primary Hepatic Angiosarcoma","volume":"50","author":"Zeng","year":"2020","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Ren, S., Wang, Y., Wang, Z., Shao, J., and Ye, Z. (2020). Survival Predictors of Metastatic Angiosarcomas: A Surveillance, Epidemiology, and End Results Program Population-Based Retrospective Study. BMC Cancer, 20.","DOI":"10.1186\/s12885-020-07300-7"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/COC.0b013e31827e4e7b","article-title":"Angiosarcoma Outcomes and Prognostic Factors: A 25-Year Single Institution Experience","volume":"37","author":"Buehler","year":"2014","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00130404-200505000-00011","article-title":"A 14-Year Retrospective Review of Angiosarcoma: Clinical Characteristics, Prognostic Factors, and Treatment Outcomes with Surgery and Chemotherapy","volume":"11","author":"Fury","year":"2005","journal-title":"Cancer J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1200\/JCO.2008.17.3146","article-title":"Phase II Trial of Weekly Paclitaxel for Unresectable Angiosarcoma: The ANGIOTAX Study","volume":"26","author":"Penel","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1038\/modpathol.2013.176","article-title":"Malignant Vascular Tumors\u2014An Update","volume":"27","author":"Antonescu","year":"2014","journal-title":"Mod. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/tbj.13504","article-title":"Radiation-Induced Angiosarcoma of the Breast: A Review","volume":"26","author":"Bonito","year":"2020","journal-title":"Breast J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.ejso.2015.04.022","article-title":"Primary Hepatic Angiosarcoma","volume":"41","author":"Chaudhary","year":"2015","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_27","first-page":"592","article-title":"Radiotherapy-Associated Intra-Abdominal Angiosarcoma after Prostatic Adenocarcinoma: Case Reports","volume":"9","year":"2018","journal-title":"Mol. Clin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00000372-200208000-00009","article-title":"Angiosarcoma in a Chronically Immunosuppressed Renal Transplant Recipient: Report of a Case and Review of the Literature","volume":"24","author":"Ahmed","year":"2002","journal-title":"Am. J. Dermatopathol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Piamonti, D., Giannone, S., D\u2019Antoni, L., Sanna, A., Landini, N., Pernazza, A., Bassi, M., Carillo, C., Diso, D., and Venuta, F. (2025). Bilateral Spontaneous Hemothorax: A Rare Case of Primary Pleural Angiosarcoma and Literature Review. J. Clin. Med., 14.","DOI":"10.3390\/jcm14103377"},{"key":"ref_30","first-page":"e76849","article-title":"Ovarian Angiosarcoma with Intractable Intraperitoneal Hemorrhage: A Case Report and Review of the Literature","volume":"17","author":"Tsuchiya","year":"2025","journal-title":"Cureus"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1089\/jpm.2018.0466","article-title":"Terminal Bleeding in Angiosarcoma","volume":"22","author":"Gill","year":"2019","journal-title":"J. Palliat. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1159\/000346398","article-title":"Angiosarcoma Involving Solid Organs and the Gastrointestinal Tract with Life-Threatening Bleeding","volume":"6","author":"Maeyashiki","year":"2012","journal-title":"Case Rep. Gastroenterol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/cncr.11667","article-title":"Cutaneous Angiosarcoma of the Scalp: A Multidisciplinary Approach","volume":"98","author":"Pawlik","year":"2003","journal-title":"Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1093\/annonc\/mdm381","article-title":"Angiosarcomas, a Heterogeneous Group of Sarcomas with Specific Behavior Depending on Primary Site: A Retrospective Study of 161 Cases","volume":"18","author":"Fayette","year":"2007","journal-title":"Ann. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s12254-017-0365-x","article-title":"Anti-Angiogenic Therapies for the Treatment of Angiosarcoma: A Clinical Update","volume":"10","author":"Young","year":"2017","journal-title":"MEMO"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.athoracsur.2010.09.079","article-title":"Outcomes after Right-Side Heart Sarcoma Resection","volume":"91","author":"Kim","year":"2011","journal-title":"Ann. Thorac. Surg."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e000787","DOI":"10.1136\/esmoopen-2020-000787","article-title":"Evaluation of the Use and Efficacy of (Neo)Adjuvant Chemotherapy in Angiosarcoma: A Multicentre Study","volume":"5","author":"Constantinidou","year":"2020","journal-title":"ESMO Open"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s40425-019-0689-7","article-title":"Angiosarcoma Patients Treated with Immune Checkpoint Inhibitors: A Case Series of Seven Patients from a Single Institution","volume":"7","author":"Florou","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e002990","DOI":"10.1136\/jitc-2021-002990","article-title":"Multicenter Phase II Trial (SWOG S1609, Cohort 51) of Ipilimumab and Nivolumab in Metastatic or Unresectable Angiosarcoma: A Substudy of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART)","volume":"9","author":"Wagner","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/pon.5007","article-title":"Health-Related Quality of Life, Psychosocial Functioning, and Unmet Health Needs in Patients with Sarcoma: A Systematic Review","volume":"28","author":"McDonough","year":"2019","journal-title":"Psychooncology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa1000678","article-title":"Early Palliative Care for Patients with Metastatic Non-Small-Cell Lung Cancer","volume":"363","author":"Temel","year":"2010","journal-title":"N. Engl. J. Med."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/13\/2101\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:57:14Z","timestamp":1760032634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/13\/2101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":41,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["cancers17132101"],"URL":"https:\/\/doi.org\/10.3390\/cancers17132101","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]}}}